IPO registrations (S-1, F-1) · Registrants
Carmot Therapeutics Inc.
- SEC CIK
- 1490109 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2023-11-17, last 2023-11-20; 1 initial registration, 1 amendment
- Outcome
- Withdrawal requested 2023-12-11
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 740 HEINZ AVENUE, Berkeley, CA 94710
- EIN
- 26-1872684
- EDGAR entity type
- other
Offering terms
- Listing
- Nasdaq under the symbol CRMO
- Lead underwriters
- J.P. Morgan; BofA Securities; Piper Sandler; Guggenheim Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CARMOT THERAPEUTICS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: CARMOT THERAPEUTICS INC. EXACT (EIN (EXACT))
- Federal award recipient: CARMOT THERAPEUTICS INC. Fuzzy (name and state)
- Form D issuer: Carmot Therapeutics Inc. EXACT (CIK (EXACT))
Filings 3
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2023-11-17 | S-1 | S-1 (registration) | Carmot Therapeutics Inc. | 0001193125-23-279847 ↗ |
| 2023-11-20 | S-1/A | S-1/A (amendment) | Carmot Therapeutics Inc. | 0001193125-23-280749 ↗ |
| 2023-12-11 | RW | RW (withdrawal request) | Carmot Therapeutics Inc. | 0001193125-23-292626 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | S-1/A | registration statement | $9.09 | - | - | Nasdaq CRMO | 4 | primary document; price line, cover names 4 | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-06-06 | Carmot Therapeutics Inc. | Biotechnology | $149,999,802 | $149,999,802 | 25 | 1 |
| 2022-08-08 | Carmot Therapeutics Inc. | Biotechnology | $160,671,809 | $160,671,809 | 15 | 1 |
| 2020-10-01 | Carmot Therapeutics Inc. | Biotechnology | $46,882,157 | $26,282,207 | 6 | 1 |
| 2017-08-25 | Carmot Therapeutics Inc. | Biotechnology | $15,374,764 | $10,795,943 | 4 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CARMOT THERAPEUTICS, INC. | CA | State business registries | name and state |
| Federal award recipient | CARMOT THERAPEUTICS INC. | CA | Federal spending (USAspending) | name and state |
| Form D issuer | Carmot Therapeutics Inc. | CA | Form D private offerings | CIK (EXACT) |
| Patent assignee | Carmot Therapeutics Inc. | CA | Patents (USPTO) | name and state |
| Form 5500 plan sponsor | CARMOT THERAPEUTICS INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.